Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Infectious mononucleosis
MeSH D007244 - infectious mononucleosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020031:
Epstein-barr virus infections
46 Companies
3 Drugs
$
Success rate
D007960:
Leukocyte disorders
0 Companies
0 Drugs
Success rate
D008232:
Lymphoproliferative disorders
2 Companies
2 Drugs
$
Success rate
D007244:
Infectious mononucleosis
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100
%
1/1
Phase 2
0
%
0/4
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bristol Myers Squibb
Idecabtagene vicleucel
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use